Ken Griffin Maravai Lifesciences Holdings, Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 60,500 shares of MRVI stock, worth $189,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,500

Previous 39,100 54.73%

Holding current value

$189,970

Previous $324,000 1.54%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.42 - $8.5 $92,682 - $178,236	20,969 New	20,969 $114,000
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $600,341 - $990,957	87,386 Added 32.35%	357,549 $2.56 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $4.47 Million - $7.67 Million	-875,519 Reduced 76.42%	270,163 $2.34 Million
Q4 2023 Feb 14, 2024	SELL	$4.7 - $9.87 $2.9 Million - $6.08 Million	-616,448 Reduced 34.98%	1,145,682 $7.5 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $16 Million - $22.4 Million	1,745,774 Added 10673.6%	1,762,130 $17.6 Million
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $6.1 Million - $7.56 Million	-504,201 Reduced 96.86%	16,356 $203,000
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $315,332 - $400,052	24,275 Added 4.89%	520,557 $7.29 Million
Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $16.6 Million - $32.9 Million	-1,327,883 Reduced 72.79%	496,282 $7.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $34.8 Million - $51.3 Million	1,687,956 Added 1239.24%	1,824,165 $46.6 Million
Q2 2022 Aug 15, 2022	SELL	$26.05 - $37.48 $7.78 Million - $11.2 Million	-298,682 Reduced 68.68%	136,209 $3.87 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $4.59 Million - $7.68 Million	187,588 Added 75.85%	434,891 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $37.5 Million - $49.2 Million	-1,070,096 Reduced 81.23%	247,303 $10.4 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $24.1 Million - $39.7 Million	655,686 Added 99.09%	1,317,399 $64.7 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $11.1 Million - $15.4 Million	341,175 Added 106.44%	661,713 $27.6 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $22 Million - $32.8 Million	-852,991 Reduced 72.69%	320,538 $11.4 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $28.8 Million - $36.2 Million	1,173,529 New	1,173,529 $32.9 Million

Others Institutions Holding MRVI

# of Institutions

203

Shares Held

138M

Call Options Held

271K

Put Options Held

37.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $413M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account